CFA
RIGL icon

Carroll Financial Associates’s Rigel Pharmaceuticals RIGL Stock Holding History

Carroll Financial Associates’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$0 Hold
17
– – ﹤0.01% 1878
2021
Q3 		$0 Hold
17
– – ﹤0.01% 1912
2021
Q2 		$0 Hold
17
– – ﹤0.01% 1829
2021
Q1 		$0 Buy
+17
New +$673 ﹤0.01% 1738

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Carroll Financial Associates's RIGL Position: Q4 2021 in Review

Carroll Financial Associates held its Rigel Pharmaceuticals (RIGL) position steady in Q4 2021 at 17 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1878.

Carroll Financial Associates first reported a position in RIGL in Q1 2021 and has held it in 4 quarters since. 162 funds tracked by Wall St. Rank hold RIGL as of Q4 2021.

  • Carroll Financial Associates held 17 shares of Rigel Pharmaceuticals worth $0 as of Q4 2021.
  • Carroll Financial Associates left its Rigel Pharmaceuticals share count unchanged in Q4 2021.
  • Rigel Pharmaceuticals made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1878 holding.
  • Carroll Financial Associates first reported a position in Rigel Pharmaceuticals in Q1 2021 and has held it in 4 quarters since.
  • 162 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.